심장 조직 공학 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 예측 기간의 성장은 전임상시험 플랫폼에 대한 투자 증가, 만성 심장 질환의 유병률의 상승입니다. 주요 동향에는 조직 공학에서의 AI 통합, 나노기술 기반 비계의 발전, 생분해성 하이드로겔의 개발, 3D 바이오프린팅 정밀도의 진보, 조직 성숙을 위한 바이오리액터의 사용, 심장세포 강화 등이 있습니다.
심장혈관 질환의 유병률 증가는 심장 조직 공학 시장의 성장을 가속할 것으로 예측됩니다. 심혈관 질환 증가는 식생활의 혼란, 운동 부족, 흡연, 비만과 당뇨병률의 상승 등, 건강에 해로운 라이프 스타일의 선택에 크게 기인하고 있습니다. 심장 조직 공학은 생체 재료, 세포 기반 치료법 및 생체 공학 조직을 활용하여 손상된 심장 근육을 복구 또는 재생하고 심장 기능을 회복함으로써 심혈관 질환을 해결합니다. 예를 들어, 2023년 5월 미국 정부 기관인 질병통제예방센터는 18세 이상 여성 성인의 관상동맥 심장 질환 유병률이 2022년 3.6%에서 2023년 3.7%로 소폭 증가했다고 보고했습니다.
심장 조직 공학 시장의 주요 기업은 심혈관 질환 치료를 위한 창약의 정확성과 효율성을 향상시키기 위해 3D 인공 근육 조직과 같은 기술적 진보에 주력하고 있습니다. 3D 엔지니어링 근육 조직은 인간 근육의 구조적 및 기능적 특성을 모방한 생명공학 구조물로, 주로 약물 테스트 및 질병 모델링에 사용됩니다. 예를 들어, 2022년 7월 미국 소재 생명공학 회사인 Curi Bio는 인간과 관련된 3D 심장 및 골격 공학 근육 조직(EMT)의 수축성을 분석하는 Mantarray 플랫폼을 도입했습니다. 이 플랫폼은 첨단 조직 배양 기술을 활용하여 자연 근육의 기계적 특성과 동작을 복제하는 고기능성 근육 조직을 생성하여 약물 테스트를 위한 보다 정밀한 모델을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 심장 조직 공학 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 심장 조직 공학 시장 : 성장률 분석
- 세계의 심장 조직 공학 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 심장 조직 공학 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 심장 조직 공학 전체 시장(TAM)
제6장 시장 세분화
- 세계의 심장 조직 공학 시장 : 제품별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 심장 판막
- 혈관 이식
- 세계의 심장 조직 공학 시장 : 소재별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 줄기세포
- 스캐폴드
- 세계의 심장 조직 공학 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 심근경색
- 심장 판막 수술 또는 교체
- 선천성 심장병 치료
- 기타 용도
- 세계의 심장 조직 공학 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 및 진료소
- 학술연구기관
- 기타 최종 사용자
- 세계의 심장 조직 공학 시장 : 심장 판막 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 생체 인공 심장 판막
- 기계식 심장 판막
- 조직 공학 심장 판막
- 세계의 심장 조직 공학 시장 : 혈관 이식 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 합성 혈관 이식
- 생물학적 혈관 이식
- 조직 공학 혈관 이식
제7장 지역별/국가별 분석
- 세계의 심장 조직 공학 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 심장 조직 공학 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 심장 조직 공학 시장 : 경쟁 구도
- 심장 조직 공학 시장 : 기업 프로파일
- Biotronik SE & Co. KG 개요, 제품 및 서비스, 전략 및 재무 분석
- Terumo Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
- Artivion Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Tissue Regenix Group plc 개요, 제품 및 서비스, 전략 및 재무 분석
- PromoCell GmbH 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Xeltis AG
- Carmat SA
- Bioheart Inc.
- Prellis Biologics Inc.
- Cytograft Tissue Engineering Inc.
- Avery Therapeutics Inc.
- Vascudyne Inc.
- Auto Tissue Berlin GmbH
- CorMatrix Cardiovascular Inc.
- Humacyte Inc.
- BioCardia Inc.
- Osiris Therapeutics Inc.
- StemCells Inc.
- ViroMed Co. Ltd.
- Cardio3 Biosciences
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 심장 조직 공학 시장(2029년) : 새로운 기회를 제공하는 국가
- 심장 조직 공학 시장(2029년) : 새로운 기회를 제공하는 부문
- 심장 조직 공학 시장(2029년) : 성장 전략
제36장 부록
KTH
Cardiac tissue engineering involves advanced biomedical techniques to develop functional heart tissue for repairing or regenerating damaged heart muscles. This field integrates cells, biomaterials, and bioactive factors to create engineered tissues that restore cardiac function and support heart disease treatment.
The primary products in cardiac tissue engineering include heart valves and vascular grafts. Heart valves regulate blood flow within the heart, ensuring proper circulation. The key materials used are stem cells and scaffolds. Applications range from myocardial infarction treatment and heart valve repair or replacement to congenital heart disease management and more. These technologies are utilized by hospitals and clinics, academic and research institutes, and other healthcare providers.
The cardiac tissue engineering market research report is one of a series of new reports from The Business Research Company that provides cardiac tissue engineering market statistics, including cardiac tissue engineering industry global market size, regional shares, competitors with a cardiac tissue engineering market share, detailed cardiac tissue engineering market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac tissue engineering industry. This cardiac tissue engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiac tissue engineering market size has grown rapidly in recent years. It will grow from $0.67 billion in 2024 to $0.81 billion in 2025 at a compound annual growth rate (CAGR) of 19.7%. The growth during the historic period was driven by organ donor shortages, the increasing prevalence of cardiovascular diseases, innovations in biomaterials, rising investment in regenerative medicine, demand for personalized medicine, advancements in bioreactor systems, increasing government funding for biomedical research, and a growing focus on minimally invasive therapies.
The cardiac tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $1.64 billion in 2029 at a compound annual growth rate (CAGR) of 19.4%. The projected growth in the forecast period is driven by increasing demand for personalized cardiac therapies, a rising focus on bioengineered heart tissues, the expansion of regenerative medicine applications, growing collaborations between biotech firms and academia, increased investment in preclinical testing platforms, and the rising prevalence of chronic heart diseases. Key trends include the integration of AI in tissue engineering, advancements in nanotechnology-based scaffolds, the development of biodegradable hydrogels, progress in 3D bioprinting precision, the use of bioreactors for tissue maturation, and gene editing for cardiac cell enhancement.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the cardiac tissue engineering market. Cardiac tissue engineering is an interdisciplinary field dedicated to creating biological or bioartificial constructs to repair, regenerate, or replace damaged heart tissue. The rise in cardiovascular diseases is largely attributed to unhealthy lifestyle choices, including poor diet, physical inactivity, smoking, and rising obesity and diabetes rates. Cardiac tissue engineering addresses cardiovascular diseases by utilizing biomaterials, cell-based therapies, and bioengineered tissues to repair or regenerate damaged heart muscle and restore cardiac function. For example, in May 2023, the Centers for Disease Control and Prevention, a US-based governmental organization, reported that the prevalence of coronary heart disease among female adults aged 18 and over slightly increased to 3.7% in 2023 from 3.6% in 2022. Consequently, the rising incidence of cardiovascular diseases is fueling the expansion of the cardiac tissue engineering market.
Leading companies in the cardiac tissue engineering market are focusing on technological advancements, such as 3D-engineered muscle tissues, to improve the accuracy and efficiency of drug discovery for cardiovascular disease treatments. 3D-engineered muscle tissues are bioengineered constructs that mimic the structural and functional properties of human muscle, primarily used for drug testing and disease modeling. For instance, in July 2022, Curi Bio Inc., a US-based biotechnology company, introduced the Mantarray platform for analyzing contractility in human-relevant 3D heart and skeletal engineered muscle tissue (EMT). This platform leverages advanced tissue culture techniques to generate highly functional muscle tissues that replicate the mechanical properties and behavior of natural muscle, providing a more precise model for drug testing. The technology enhances the development of therapeutic solutions by enabling researchers to study muscle contraction, responses to stimuli, and disease modeling at a cellular level.
In April 2024, Valo Health LLC, a US-based technology company, acquired TARA Biosystems Inc. for an undisclosed amount. Through this acquisition, Valo Health aims to leverage TARA's proprietary human cardiac disease platform to advance the discovery of new medicines for cardiovascular diseases. TARA Biosystems Inc. is a US-based company specializing in the development of 3D-engineered cardiac tissue models for drug discovery and disease modeling.
Major players in the cardiac tissue engineering market are Biotronik SE & Co. KG, Terumo Corporation, Artivion Inc., Tissue Regenix Group plc, PromoCell GmbH, Xeltis AG, Carmat S.A., Bioheart Inc., Prellis Biologics Inc., Cytograft Tissue Engineering Inc., Avery Therapeutics Inc., Vascudyne Inc., Auto Tissue Berlin GmbH, CorMatrix Cardiovascular Inc., Humacyte Inc., BioCardia Inc., Osiris Therapeutics Inc., StemCells Inc., ViroMed Co. Ltd., Cardio3 Biosciences.
North America was the largest region in the cardiac tissue engineering market in 2024. The regions covered in cardiac tissue engineering report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cardiac tissue engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cardiac tissue engineering market consists of revenues earned by entities by providing services such as the development of stem cell therapy and regeneration services, tissue engineering consultation and research services, and bioreactor and biomanufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac tissue engineering market includes sales of bioengineered cardiac tissues, biomaterials, cardiac tissue constructs, tissue scaffolds, bioactive molecules, and bioreactors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiac Tissue Engineering Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cardiac tissue engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cardiac tissue engineering ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac tissue engineering market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Heart Valves, Vascular Grafts
- 2) By Material: Stem Cells, Scaffolds
- 3) By Application: Myocardial Infarction, Heart Valve Repair Or Replacement, Congenital Heart Disease Treatment, Other Applications
- 4) By End Users: Hospitals And Clinics, Academic And Research Institutes, Other End Users
- Subsegments:
- 1) By Heart Valves: Bioprosthetic Heart Valves; Mechanical Heart Valves; Tissue-Engineered Heart Valves
- 2) By Vascular Grafts: Synthetic Vascular Grafts; Biologic Vascular Grafts; Tissue-Engineered Vascular Grafts
- Companies Mentioned: Biotronik SE & Co. KG; Terumo Corporation; Artivion Inc.; Tissue Regenix Group plc; PromoCell GmbH
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cardiac Tissue Engineering Market Characteristics
3. Cardiac Tissue Engineering Market Trends And Strategies
4. Cardiac Tissue Engineering Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Cardiac Tissue Engineering Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cardiac Tissue Engineering PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cardiac Tissue Engineering Market Growth Rate Analysis
- 5.4. Global Cardiac Tissue Engineering Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cardiac Tissue Engineering Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cardiac Tissue Engineering Total Addressable Market (TAM)
6. Cardiac Tissue Engineering Market Segmentation
- 6.1. Global Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Heart Valves
- Vascular Grafts
- 6.2. Global Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Stem Cells
- Scaffolds
- 6.3. Global Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Myocardial Infarction
- Heart Valve Repair Or Replacement
- Congenital Heart Disease Treatment
- Other Applications
- 6.4. Global Cardiac Tissue Engineering Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Academic And Research Institutes
- Other End Users
- 6.5. Global Cardiac Tissue Engineering Market, Sub-Segmentation Of Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bioprosthetic Heart Valves
- Mechanical Heart Valves
- Tissue-Engineered Heart Valves
- 6.6. Global Cardiac Tissue Engineering Market, Sub-Segmentation Of Vascular Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Synthetic Vascular Grafts
- Biologic Vascular Grafts
- Tissue-Engineered Vascular Grafts
7. Cardiac Tissue Engineering Market Regional And Country Analysis
- 7.1. Global Cardiac Tissue Engineering Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cardiac Tissue Engineering Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cardiac Tissue Engineering Market
- 8.1. Asia-Pacific Cardiac Tissue Engineering Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cardiac Tissue Engineering Market
- 9.1. China Cardiac Tissue Engineering Market Overview
- 9.2. China Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cardiac Tissue Engineering Market
- 10.1. India Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cardiac Tissue Engineering Market
- 11.1. Japan Cardiac Tissue Engineering Market Overview
- 11.2. Japan Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cardiac Tissue Engineering Market
- 12.1. Australia Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cardiac Tissue Engineering Market
- 13.1. Indonesia Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cardiac Tissue Engineering Market
- 14.1. South Korea Cardiac Tissue Engineering Market Overview
- 14.2. South Korea Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cardiac Tissue Engineering Market
- 15.1. Western Europe Cardiac Tissue Engineering Market Overview
- 15.2. Western Europe Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cardiac Tissue Engineering Market
- 16.1. UK Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cardiac Tissue Engineering Market
- 17.1. Germany Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cardiac Tissue Engineering Market
- 18.1. France Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cardiac Tissue Engineering Market
- 19.1. Italy Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cardiac Tissue Engineering Market
- 20.1. Spain Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cardiac Tissue Engineering Market
- 21.1. Eastern Europe Cardiac Tissue Engineering Market Overview
- 21.2. Eastern Europe Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cardiac Tissue Engineering Market
- 22.1. Russia Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cardiac Tissue Engineering Market
- 23.1. North America Cardiac Tissue Engineering Market Overview
- 23.2. North America Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cardiac Tissue Engineering Market
- 24.1. USA Cardiac Tissue Engineering Market Overview
- 24.2. USA Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cardiac Tissue Engineering Market
- 25.1. Canada Cardiac Tissue Engineering Market Overview
- 25.2. Canada Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cardiac Tissue Engineering Market
- 26.1. South America Cardiac Tissue Engineering Market Overview
- 26.2. South America Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cardiac Tissue Engineering Market
- 27.1. Brazil Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cardiac Tissue Engineering Market
- 28.1. Middle East Cardiac Tissue Engineering Market Overview
- 28.2. Middle East Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cardiac Tissue Engineering Market
- 29.1. Africa Cardiac Tissue Engineering Market Overview
- 29.2. Africa Cardiac Tissue Engineering Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cardiac Tissue Engineering Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cardiac Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cardiac Tissue Engineering Market Competitive Landscape And Company Profiles
- 30.1. Cardiac Tissue Engineering Market Competitive Landscape
- 30.2. Cardiac Tissue Engineering Market Company Profiles
- 30.2.1. Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Artivion Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Tissue Regenix Group plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. PromoCell GmbH Overview, Products and Services, Strategy and Financial Analysis
31. Cardiac Tissue Engineering Market Other Major And Innovative Companies
- 31.1. Xeltis AG
- 31.2. Carmat S.A.
- 31.3. Bioheart Inc.
- 31.4. Prellis Biologics Inc.
- 31.5. Cytograft Tissue Engineering Inc.
- 31.6. Avery Therapeutics Inc.
- 31.7. Vascudyne Inc.
- 31.8. Auto Tissue Berlin GmbH
- 31.9. CorMatrix Cardiovascular Inc.
- 31.10. Humacyte Inc.
- 31.11. BioCardia Inc.
- 31.12. Osiris Therapeutics Inc.
- 31.13. StemCells Inc.
- 31.14. ViroMed Co. Ltd.
- 31.15. Cardio3 Biosciences
32. Global Cardiac Tissue Engineering Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cardiac Tissue Engineering Market
34. Recent Developments In The Cardiac Tissue Engineering Market
35. Cardiac Tissue Engineering Market High Potential Countries, Segments and Strategies
- 35.1 Cardiac Tissue Engineering Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cardiac Tissue Engineering Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cardiac Tissue Engineering Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
